Inference of phenotype-relevant transcriptional regulatory networks elucidates cancer type-specific regulatory mechanisms in a pan-cancer study
Abstract
Reconstruction of transcriptional regulatory networks (TRNs) is a powerful approach to unravel the gene expression programs involved in healthy and disease states of a cell. However, these networks are usually reconstructed independent of the phenotypic properties of the samples and therefore cannot identify regulatory mechanisms that are related to a phenotypic outcome of interest. In this study, we developed a new method called InPheRNo to identify phenotype-relevant transcriptional regulatory networks. This method is based on a probabilistic graphical model whose conditional probability distributions model the simultaneous effects of multiple transcription factors (TFs) on their target genes as well as the statistical relationship between target gene expression and phenotype. Extensive comparison of InPheRNo with related approaches using primary tumor samples of 18 cancer types from The Cancer Genome Atlas revealed that InPheRNo can accurately reconstruct cancer type-relevant TRNs and identify cancer driver TFs. In addition, survival analysis revealed that the activity level of TFs with many target genes could distinguish patients with good prognosis from those with poor prognosis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 15
- FWCI
- 0.27
- Field percentile
- top 47%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pan-cancer transcriptional regulatory network analysis reveals key drivers and epigenetic modulators in tumorigenesis
Yaluan Yin, Junhua Zhang·bioRxiv·Mar 18, 2025
- TopicNet: a framework for measuring transcriptional regulatory network change
Shaoke Lou, Tianxiao Li, … Mark Gerstein·BioinformaticsPeer-reviewed·May 9, 2020
- Identification of candidate master transcription factors within enhancer-centric transcriptional regulatory networks
Alexander Joel Federation, Donald R. Polaski, … James E. Bradner·bioRxiv·Jun 12, 2018
- Pan-cancer analysis of patient-specific gene regulatory landscapes identifies recurrent PD-1 pathway dysregulation linked to outcome
Tatiana Belova, Ping‐Han Hsieh, … Marieke L. Kuijjer·bioRxiv·Oct 3, 2025
- Transcription factor activities enhance markers of drug response in cancer
L. Garcia-Alonso, F. Iorio, … J. Saez-Rodriguez·bioRxiv·Apr 21, 2017
- Discovery of novel therapeutic targets in cancer using patient-specific gene regulatory networks.
Andre Neil Forbes, Duo Xu, … Ekta Khurana·bioRxiv·Jan 31, 2022